13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 68 holding rows worth $2,101,757,147.
- Accession
- 0001104659-23-118113
- Filer
- CIK 1425738
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 68 entries on the cover page, a total value of $2,101,757,147 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,101,757,147 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 17,503,417 | $277,779,228 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 2,003,367 | $232,390,572 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 16,944,621 | $206,046,591 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,769,684 | $89,510,617 | dollars as filed | |
| AUGMEDIX INC | 05105P107 | COM | 15,630,327 | $80,496,184 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 4,163,922 | $71,244,705 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 1,100,492 | $58,194,017 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 4,475,384 | $56,926,884 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,678,099 | $46,438,237 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,635,938 | $45,021,014 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 2,574,042 | $42,368,731 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,102,514 | $42,325,512 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 1,857,706 | $41,241,073 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 774,200 | $40,877,760 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 873,966 | $39,791,672 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 155,076 | $37,514,435 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 85,378 | $37,175,289 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 5,661,230 | $35,892,198 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,469,725 | $35,346,886 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 4,733,248 | $33,606,061 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 929,900 | $32,295,427 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 59,851 | $29,118,709 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,404,695 | $29,048,716 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 13,124,427 | $27,823,785 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,774,252 | $27,004,115 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 1,868,507 | $25,972,247 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 94,738 | $25,889,053 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 2,971,542 | $24,812,376 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 244,391 | $22,801,680 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,848,827 | $22,391,780 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 1,284,000 | $20,287,200 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,053,333 | $20,019,997 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 3,872,696 | $15,258,422 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 8,509,126 | $14,635,697 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 419,568 | $14,332,443 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 518,924 | $13,497,213 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 66,382 | $13,009,544 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 14,178,045 | $12,717,706 | dollars as filed | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 465,282 | $12,669,629 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,324,350 | $12,634,299 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 761,955 | $11,764,585 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 809,777 | $10,737,643 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 8,031,094 | $10,601,044 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 4,135,061 | $9,386,588 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 6,280,813 | $9,295,603 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 5,765,792 | $9,109,951 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,619,914 | $8,542,269 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 3,503,190 | $8,267,528 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 19,808,234 | $7,923,294 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 427,490 | $7,104,884 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,283,289 | $6,159,787 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 24,667 | $6,067,589 | dollars as filed | |
| MEDAVAIL HOLDINGS INC COM NEW | 58406B202 | NEW | 692,082 | $4,194,017 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 1,907,969 | $4,102,133 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,031,009 | $4,061,552 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,074,372 | $3,090,814 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,440,725 | $2,449,233 | dollars as filed | |
| NEOLEUKIN THERAPEUTICS INC | 64049K203 | COM NEW | 582,443 | $2,300,650 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 334,996 | $2,016,676 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,046,587 | $1,946,652 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,608,089 | $1,463,200 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 2,280,403 | $1,380,100 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 399,439 | $954,659 | dollars as filed | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 284,564 | $793,934 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 1,063,769 | $655,282 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 715,607 | $558,173 | dollars as filed | |
| SONENDO INC | 835431107 | Common Stocks | 410,393 | $306,071 | dollars as filed | |
| ATRECA INC | 04965G109 | COM | 442,653 | $115,532 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-118113 | this filing | 2023-11-14 | acceptance time not in the bulk data set |